These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Neuroleptic-induced emesis: a new indication for clozapine? Bustillo JR; Buchanan RW Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665 [No Abstract] [Full Text] [Related]
25. Pharmacokinetic studies of antipsychotics in healthy volunteers versus patients. Cutler NR J Clin Psychiatry; 2001; 62 Suppl 5():10-3; discussion 23-4. PubMed ID: 11305842 [TBL] [Abstract][Full Text] [Related]
26. New antipsychotic medications: do research results relate to clinical practice? MacEwan GW Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572 [TBL] [Abstract][Full Text] [Related]
27. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C; Bret P; Bret MC; Queuille E Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [TBL] [Abstract][Full Text] [Related]
28. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group. Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652 [No Abstract] [Full Text] [Related]
29. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine]. Stengler-Wenzke K Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713 [TBL] [Abstract][Full Text] [Related]
30. Clozapine: the commitment to patient safety. Alphs LD; Anand R J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610 [TBL] [Abstract][Full Text] [Related]
31. Seizure on low-dose clozapine. Ravasia S; Dickson RA Can J Psychiatry; 1998 May; 43(4):420. PubMed ID: 9598281 [No Abstract] [Full Text] [Related]
32. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Raskin S; Katz G; Zislin Z; Knobler HY; Durst R Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556 [TBL] [Abstract][Full Text] [Related]
33. Ethical issues in drug selection for schizophrenia. Jeffries JJ Can J Psychiatry; 1993 Sep; 38 Suppl 3():S70-4. PubMed ID: 7504571 [TBL] [Abstract][Full Text] [Related]
34. Management of treatment-resistant patients with schizophrenia. Marder SR J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168 [TBL] [Abstract][Full Text] [Related]
35. [Clozapine and treatment of negative symptoms]. Lançon C; Farisse J; Llorca PM Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403 [TBL] [Abstract][Full Text] [Related]
36. Prescribing and monitoring clozapine in Christchurch. McKean A; Vella-Brincat J; Begg E Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375 [TBL] [Abstract][Full Text] [Related]
37. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years. Mattes JA J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612 [TBL] [Abstract][Full Text] [Related]
38. New drugs for the treatment of schizophrenia. Meltzer HY Psychiatr Clin North Am; 1993 Jun; 16(2):365-85. PubMed ID: 8101373 [TBL] [Abstract][Full Text] [Related]